Integrins are transmembrane adhesion molecules that mediate cell-cell and cell-extracellular matrix attachment. Integrins regulate cell growth, proliferation, migration and apoptosis and as a consequence, can have a potential role in tumour progression and metastasis. In this study, we investigated 19 non-synonymous variants in the coding region of the human integrin genes representing 3 beta subunits and 13 alpha subunits, for their potential role in melanoma susceptibility and survival. The variants were selected on the basis of probable functional relevance and theoretical predictions. Our data showed that no genetic variant was significantly associated with survival. However, the variants in ITGA10 and ITGA6 genes showed association with decreased risk, and variants in ITGA2, ITGAE and ITGAM were associated with increased risk of melanoma. The haplotype analysis revealed association of CA haplotype of ITGAE and TAC haplotype of ITGAX with the risk modulation. A prediction analysis of functional effect, homology modelling and multiple sequence alignments of integrin sequences from different species supported our data for linkage of variants in the ITGA2 and ITGAE genes with susceptibility. The amino acid changes in each of these integrin proteins could affect intramolecularly and/or the interaction of the heterodimers. Our experimental data indicated a possible role for some of the variant alleles and/or haplotypes of the integrin genes in melanoma susceptibility, which is augmented by the theoretical analysis performed.
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Introduction
Integrins belong to a family of proteins that mediate cell-cell and cell-extracellular matrix (ECM) attachment. Structurally, integrins are heterodimeric receptors with a and b subunits, which each have a large ectodomain, a single transmembrane domain and a generally short cytoplasmic tail (1) . The activation of these molecules involves conformational changes in their structure that are essential for their function (2, 3) . Integrins have been implicated in proliferation, migration, invasion and survival (4) (5) (6) (7) (8) (9) . Anchorage-independent growth is an indication of malignant transformation. In tumour cells, adhesion-dependant signals that lead to cell proliferation are deregulated and thereby the control of integrin adhesion to the ECM is essential for tumour cell invasion. Tumour growth and metastasis can be affected by unligated integrins that can influence tumour cell survival in a positive or negative way (10) (11) (12) .
Metastasis is a process that depends on the ability of the tumour cell to complete a gradual series of events that include tumour cell intravasation, adhesion to the vesel wall, extravasation at the metastatic site infiltration and proliferation of the tumor cell within the target tissue. Many of these steps involve the participation of integrin receptors. In the case of human cutaneous malignant melanoma, a potentially fatal neoplasm with complex and heterogeneous aetiology, several integrin receptors have been found to be dysregulated mainly in primary and metastatic cells (13) and many studies have shown that the expression of these ECM receptors is frequently changed during malignant transformation (10) . Furthermore, up-regulation of integrins expression was associated with the acquisition of a more metastatic phenotype (14, 15) . Various polymorphisms in those genes were found to be associated with melanoma and different types of cancer. The 807C.T polymorphism in ITGA2 was indicated to be associated with reduced colorectal cancer risk. Single-nucleotide polymorphisms (SNPs) and haplotypes within ITGAV were suggested to increase the susceptibility to chronic hepatitis B virusinfected hepatocellular carcinoma in a Korean population. In addition, functional polymorphisms in ITGA2 and ITGB3 genes were found to influence the susceptibility and progression of breast cancer.
In the pursuit of investigation a role of functional polymorphisms in the integrin genes in malignant melanoma, we carried out a study of cases and controls in a German population.
Materials and methods

Study population
Seven hundred and fifty-seven patients that included 342 females and 415 males, with European ethnicity were recruited for inclusion in the study. The cases were referred to the Skin Cancer Unit, German Cancer Research Center Heidelberg, at the University Hospital Mannheim. Blood samples from the patients were collected between 2000 and 2007 and diagnoses were confirmed by histopathology. Ethical approval for the study from the Medical Ethics Committee of Faculty of Clinical Medicine Mannheim, Heidelberg University and written informed consent from all study participants were obtained. German control subjects included 736 ethnically matched healthy individuals (368 females and 368 males) recruited at the Institute of Transfusion Medicine and Immunology Mannheim (Germany). Controls were born in southwest Germany and were matched for ethnicity with cases. The inclusion criteria for controls in the study included cancer free status. Informed consent was obtained from the patients and the appropriate ethical institutional review board approved the study. Because of the anonymous condition of the donors, only age and sex were available for the study. DNA was extracted from blood samples of cases and controls using Qiagen mini-preparation kits.
Genes and SNPs selection
Twenty nine known non-synonymous SNPs in the coding regions spanning 8 beta and 12 alpha integrins reported in the dbSNP database of the National Center for Biotechnology Information, NCBI (http://www.ncbi.nlm.nih.gov/ SNP/) were selected for this study. The selected polymorphisms were first validated in a set of control German population by direct DNA sequencing. Only 22 SNPs were presented in the tested population with a MAF . 5%. Three polymorphisms could not be measured due to technical reasons. Thus, a total of 19 SNPs were finally genotyped and analysed.
Validation of the SNPs by DNA sequencing
The validation of the polymorphisms was carried out by sequencing a set of 285 (15 samples for each SNP) DNA samples from German control subjects. Sequencing reactions were performed on polymerase chain reaction (PCR) amplified products using Big Dye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and the following conditions were used; initial 94°C for 1 min followed by 27 cycles at 96°C for 16 s, 56°C for 5 s and 60°C for 4 min. The reaction products were precipitated with 2-propanol, washed with 70% ethanol, diluted in 25 ll water and loaded on an ABI prism 3100 Genetic analyser (Applied Biosystems). Primary sequencing data were analysed using a sequencing analysis program (Applied Biosystems). Primers used in PCR amplification and sequencing reaction are listed in supplementary Table I , available at Mutagenesis Online.
Prediction of functional effect of human nsSNPs
Prediction analysis was performed with 'PolyPhen' (5Polymorphism Phenotyping), a tool which predicts possible impact of an amino acid substitution on the structure and function of a human protein using straightforward physical and comparative considerations.
Genotyping
Genotyping was performed using an allelic discrimination-based method (KASPar SNP Genotyping System v2.0, K Bioscience). PCR was carried out in plates of 96 wells, in a total volume of 8 ll per well which contained 10 ng of template DNA, 2.2 mM MgCl2 (1.8 mM for rs2274616 and 1800974), 4 ll 2Â reaction Mix and 0.11 ll of assay mix. The temperature conditions for the reaction were: an initial denaturation step 94°C for 15 min, followed by 35 cycles of 94°C for 10 s, annealing at 57°C for 20 s and amplification at 72°C for 40 s. Cycling conditions for rs1801106 (ITGA2) were: an initial denaturation at 94°C for 15 s followed by 37 cycles of 94°C 10 s and 57°C 60 s. The genotype quality control was validated through random inclusion of 2% of DNA samples as replicates in each round.
Statistical analysis
The observed genotype frequencies in the controls were tested for deviation from Hardy-Weinberg equilibrium (HWE) by chi-square tests. The associations between malignant melanoma and different alleles and genotypes were estimated as odds ratios (ORs), 95% confidence intervals (CI) and P-values based on logistic regression, including age and sex as covariates (PROC LOGISTIC, SAS version 9.2). Haplotype frequencies in cases and controls were inferred using the expectation-maximization algorithm (PROC HAPLO-TYPE, SAS/Genetics Software). Afterwards, logistic regression was used to assess the relationship between haplotype and melanoma. For the genotypes and haplotypes found to be related with susceptibility, the associations with overall survival were also estimated as hazard ratio based on Cox regression, adjusting for gender, age and Breslow thickness (PROC PHREG, SAS 9.2). We assumed that every individual carries the most likely combination of possible haplotypes and that the effects of haplotypes interact multiplicatively. The cases and controls were not exactly matched for age and gender due to logistical reasons. With the given sample size, the calculations showed that the study had about 60-70 percent power to detect 30% increased or decreased risk associated with any polymorphism with 0.2 minor allele frequency at an a-value of 0.05.
Modelling and conservation analysis of polymorphisms
Sequences. For homology modelling of human integrins, the sequences with corresponding UniProt accession numbers were used, which included, alpha-2 (P17301), alpha-6 (P23229), alpha-10 (O75578), alpha-E (P38570) and alpha-M (P11215).
Sequences alignment. Sequence alignment was generated in ClustalX2 (16) . Integrin sequence for different species abbreviations: AILME (Ailuropoda melanoleuca), BOVIN (Bos taurus), CALJA (Callithrix jacchus), CANFA Homology modelling and structure analysis. Modelling of human integrins alpha-2, alpha-10, alpha-E and alpha-M ectodomains was carried out as in (17) using the MODELLER package (18) (21), respectively]. Modelling of human integrin alpha-6 ectodomain was carried out based on crystal structures of human integrin alpha-V [PDB ID 3ije chain A (22) ]. The complete models were then scored for energy and sterical correctness using the ANOLEA (23), VERIFY_3D and ERRAT (http://nihserver.mbi.u cla.edu/) online servers. Structure analysis was carried out in SwissPBD Viewer (24) and PyMol (www.pymol.org) visualisation software using PDB2PQR (25) , PropKa (26) and APBS (27) packages for charge surface calculations and HotPatch web server (28) for hydrophobicity calculations.
Results
Prediction analysis
Through the software PolyPhen, they were predicted to be possibly damaging three missense SNPs: rs267561 (ITGA9), with an amino acid change Gly507Glu in the protein, rs1716 (ITGAE) with a residue change Arg950Trp and rs1143678 (ITGAM) with a change Pro1146Ser. Another missense SNP of ITGAX gen (rs2230429) was prognosticated to be probably damaging (Pro517Arg). Additionally, regarding the conserved domains of the integrin proteins, only in rs2230428 (ITGAX) the substitution Ala251Thr was found to be comprised within the integrin inhibitor-binding pocket region. According to these predictions, these SNPs were the most likely to have a hypothetical influence in the protein function (Table I) .
Genotype analysis
In this study, we genotyped 19 polymorphisms in 757 melanoma cases and 736 healthy controls in a German population. The age of diagnosis of German cases ranged between 13 and 98 years; the mean age was 54 years (SD 16 years), and the median age 55 years. The age of controls ranged between 46 and 68 years; their mean and median ages were 60.3 years (SD 2.8 years) and 61 years, respectively. Genotype and allele distributions of all the polymorphisms are summarised in Table II . Genotype frequency in controls and cases for all the polymorphisms was in accordance with the HWE. For the rs1801106 (ITGA2), the expected genotype distribution deviated from the observed in cases (P 5 0.04); however, in controls, the genotype distribution for the polymorphism was in accordance with the HWE (P 5 0.44). The genotyping of replicates for quality controls showed 100 percent concordance.
Comparison of cases and controls showed that the difference in the distribution of the allele frequencies was marginally significant for four SNPs (Table II) : a protective effect was found for ITGA10 (rs2274616) (OR 5 0.81, 95% CI 0.66-1.00, P 5 0.05) and ITGA6 (rs11895564) (OR 5 0.81, 95% CI 0.69-0.96, P 5 0.02), whereas an increased risk to melanoma is presumed for the minor alleles in rs1831106 of ITGA2 (OR 5 1.30, 95% CI 1.02-1.65, P 5 0.03) and rs2272606 of ITGAE (OR 5 1.18, 95% CI 1.00-1.39, P 5 0.05).
According to the differential distribution of genotypes in cases and controls, the carriers of minor alleles of ITGA10 (rs2274616) (OR 5 0.78, 95% CI 0.62-0.98; P 5 0.03) and rs11895564 (ITGA6) (OR 5 0.77, 95% CI 0.63-0.96; P 5 0.02), in accordance with allelic data, were at a decreased risk of melanoma. Similarly, carriers of rs1831106 of ITGA2 (OR 5 1.31, 95% CI 1.01-1.71; P 5 0.05) and rs2272606 of ITGAE (OR 5 1.25, 95% CI 1.01-1.54; P 5 0.04) were at an increased risk. In addition, the TT-homozygous for the minor allele for the rs1143683 (ITGAM) were at an increased risk (OR 2.49, 95% CI 1.18-5.27, P 5 0.02).
Haplotype analysis
Haplotypes were inferred for polymorphisms located within the same gene or gene regions and distributions between cases and controls were compared. Linkage disequilibrium (LD) between SNP markers was checked prior to estimating haplotypes and none of the variants showed to be in LD with other investigated variants at a r 2 5 0.8. The analysis resulted in the inference of four haplotypes for ITGA11 (15q23), ITGAE (17p13) and ITGAM (16p 11.2) and eight haplotypes each for ITGAX gene (16p 11.2) (Table III) . In all cases, the most frequent haplotype was the one without any variant allele. According to our results, no significant difference in haplotype distribution was found for ITGA11 in cases and controls. The less common haplotype of ITGAE (CA) showed an evidence for an increased susceptibility to the disease (OR 5 1.38, 95% CI 1.08-1.77, P 5 0.01). The CT haplotype of ITGAM was associated with an increased risk (OR 5 2.44, 95% CI 1.12-5.32, P 5 0.03) and TC haplotype of the same gene showed an association with increased risk with an OR 5 5.24 (95% CI 1.79-15.31, P 5 0.002). The CGG (OR 5 0.32, 95% CI 0.14-0.71, P 5 0.006) and TAC haplotypes (OR 5 0.60, 95% CI 0.44-0.82, P 50.001) of the ITGAX gene were found to be protective. It is noteworthy that only CA of ITGAE and TAC of ITGAX haplotypes were the ones that were present at a frequency more than 5% in the investigated population. Since ITGAM and ITGAX are both on chromosome 16p11.22 separated only by 22 kb, we also inferred haplotypes for the five SNPs of these two genes together, but out of a total of 31 estimated haplotypes, four were associated with statistically significant risk. However, the frequencies of haplotypes in cases and controls were ,5% (data not shown).
Survival analysis
We performed a 10 years survival analysis to evaluate the influence of the genotypes on metastasis free progression, the overall survival and the time from metastasis to death. The survival analysis was carried out on 540 patients who presented either in situ or stage I or II melanoma at the time of diagnosis. At 10-year time point, 123 patients had died of the disease. For those patients in addition to information about the disease stage, the data about age, gender and Breslow thickness were also available and incorporated in the analysis. None of the investigated polymorphisms and haplotypes showed any association with survival (supplementary Tables II and III,  available at Mutagenesis Online).
Conservation of SNPs and structural analysis
According to our genotyping results, we performed homology modelling and multiple sequence alignments of integrin sequences from different species with the aim of investigating how the missense mutations in human integrin genes described here might influence the protein structure and also to study the conservation of the residues affected by the SNPassociated amino acid exchange. Those integrins were considered in which SNPs with a statistically association had been detected. To this end, the structures of the human integrin alpha-2 (ITGA2) and integrin alpha-E ectodomain were superimposed on the structure of human integrin beta-2 subunit (Figures 1  and 2 ). Residue 534 of ITGA2 is located in the region that could be important both for intramolecular interaction within the alpha-2 subunit and intermolecular interactions between alpha and beta subunits (Figure 1) . The distribution of charges on the surface of integrin alpha-2 in the region of residue 534 is altered when this residue is changed from the positively charged Lys (K) to the negatively charged Glu (E). This significant change in local charge distribution in this region could play a role as in intramolecular or in intermolecular interactions. With regard to the alignment of residue 534 in human integrin alpha-2 receptor ( Figure 3A and B) , there are two integrin alpha-2 sequences referred to as wild type in different databases: HUMAN1 with Glu534 (NCBI ID NP_002194) and HUMAN2 with Lys534 (UniProt ID P17301). The alignment shows that ITGA2 residue Lys534 is evolutionarily conserved across species, although, in our case, the G allele (codon GAG coding for Glu) was found with a higher frequency in our Caucasian population than the obviously ancestral allele A which, in the context of an AAG codon codes for the amino acid Lys. Otherwise this residue was not conserved within other integrin family members. In the structural analysis of mutation of the residue 482 of human integrin alpha-E receptor (Figure 2 ), we observed that it is located in the region which could be important for intermolecular interaction between alpha and beta subunits. In this case, the distribution of the charge on the surface of integrin alpha-E in the region of residue 482 is altered when Arg (positively charged) is changed to Gln (polar, uncharged) and consequently, this leads to a dramatic change in local charge distribution in this region which could play a role in intermolecular interactions. In addition, residue 482 in human ITGAE is relatively conserved across species as well as at the family level ( Figure 3C and D) .
For the human integrin alpha-6 ectodomain, the structure was superimposed on the structure of human integrin beta-3 subunit (supplementary Figure 1 , available at Mutagenesis Online). Residue 419 in the full-length receptor is located inside the barrel structure of the von Willebrand Factor type A (VWFA) domain. The change from the small amino acid Alanine to the more bulky Threonine could lead to a perturbation of the barrel structure of the VWFA domain and may influence interaction of the alpha subunit with the beta subunit that could be formed between the VWFA domain and beta subunit. As for human integrin alpha-10 and alpha-M ectodomains, these sequences were superimposed with the structure of human integrin beta-2 subunit in our modelling approach (supplementary Figures 2 and 3 , available at Mutagenesis Online) and we observed that both residues, 725 of ITGA10 and residue 858 of ITGAM, are located on opposite sides of the beta subunit interaction interface. It is evident from our sequence alignment that the residue 380 in ITGA6, as well as the residue 725 in ITGA10 is both rather conserved in other intergrin orthologue sequences, whereas residue 858 of human integrin alpha-M receptor is not so highly conserved. And analysis within the family of integrin proteins showed that only Figure 4 , available at Mutagenesis Online).
Discussion
Association of integrins with different cancers is generally due to aberrant expression of the genes (5). However, data also show that tumour-associated mutations and polymorphisms in coding regions of the genes encoding various integrins have potential to influence the cancer susceptibility and disease outcome (6, 29, 30) . In the case of malignant melanoma, observations suggest that different integrin molecules influence the contact between malignant cells and the ECM (13) . This important cell-cell and cell-ECM contact can theoretically impact tumour behaviour and therefore polymorphisms within the genes encoding integrin can alter the phenomenon and consequently affect disease outcome. In this study, we investigated 19 SNPs representing genes encoding three beta subunits (3, 4 and 5) and 13 alpha subunits (2, 2b, 3, 4, 6, 7, 9, 10, 11, E, L, M) of human integrins, in order to study survival and susceptibility to melanoma cases from Germany and ethnically matched controls. A general conclusion according to our findings is that we found no strong convincing evidence for an association between the polymorphisms in the investigated integrin genes and the risk of melanoma. Nevertheless, we did find small effects due to polymorphisms in the ITGA2, ITGAE, ITGA6, ITGA10 and ITGAM genes, which keeping in consideration the correction for multiple hypotheses, could only represent a chance finding. The association of variant A-allele for the polymorphism in the ITGAE gene with increased risk was also evidenced by haplotype analysis as an increased risk was observed with CA haplotype. A haplotype TAC in ITGAX was associated with a decreased risk. Since both haplotypes were distributed with a frequency higher than 5% in the population, it would imply that the carriers could be predisposed or protected from the risk of developing melanoma in our population.
Prior literature reported up and down-regulation of different alpha and beta subunits in primary and metastatic melanoma . Exchange Lys to Glu leads to the dramatic change in local charge distribution in this region, which could play a role as in intramolecular or in intermolecular interactions. (13, 31, 32) . Some of the expressed integrin genes correlated with melanoma progression are avb3, with a phenotype associated to vertical growth phase and a5b1, associated with lymph node metastasis (10, 33) . Regarding genetic variants, previous studies have shown that T188I in the I-like domain of beta1 integrins increase the susceptibility of the epidermis to develop malignant tumours of skin and also reduced tumour differentiation (34) . Also the heterodimer alphaV beta3 is highly involved in the development of malignant melanoma and other tumours. An increased risk of cancer was described for individuals homozygous for the Leu33Pro polymorphism of the beta3 integrin subunit. Furthermore, this variant is involved in the invasion of human melanoma cells (35) . Similarly, in human melanoma cells, a naturally occurring alternatively spliced variant of the truncated b3 integrin was reported that truncated bet3 may act as an anti-integrin and play a crucial role in cell migration. The truncated bet3 was reported to inhibit adhesion of melanoma cells to fibronectin and vitronectin (6, 35) . Integrins show structural diversity, flexibility and dynamism to mediate their functions where conformational changes, unlike surface expression or clustering, are basic to their regulation (1) . For this reason, we attempted to predict how a change in an amino acid residue could influence on the protein folding and in its structure, with the possibility of affecting its function and we also examined if the position of the amino acid change mapped within a conserved domain of the integrin protein and therefore, potentially might have an influence on its activity. In order to achieve this goal, we initially made a prediction of the functional effect of the amino acid substitution due to the polymorphisms selected for this study. For the genes where variants showed differential distribution between cases and controls, we also investigated structural models of the encoded proteins. In addition, conservation across species and within families was analysed in order to study their evolution and function, assuming that amino acid residues conserved are most likely to play an important role in the protein.
From our analysis, we concluded that at least the structural analysis of ITGA2 and ITGAE support our genotyping findings, as the observed amino acid changes in both integrin proteins could affect the intramolecular and/or the alpha/beta interaction of the heterodimers. In addition, both residues showed a high level of evolutionary conservation and, by implication, they are likely to retain some important function, particularly residue 482 of ITGAE. That residue was also found to be highly conserved within the integrin family. In the case of ITGA6, the amino acid substitution could be important for maintaining the structure of the barrel of VWFA domain and may be could also influence the interaction with the beta subunit. Residue 725 of ITGA10 showed to be evolutionary quite conserved. Nonetheless, the functional role of these residues analysed remains to be tested.
Relevance of integrins and its variants related to risk of melanoma seems to be more complex than investigated in this study. We limited our work to a screening of coding SNPs in the integrin genes; however, substantial additional analysis should be performed considering the existence of polymorphisms in the promoter region of these genes, that could exert an influence in the transcription, as well as those intron and 3#UTR variations that could affect splicing sites and gene expression. Although we concentrated on the examination of genetic variants in the protein subunits, often found to be dysregulated in malignant melanoma compared to normal melanocytes (13) . It cannot be totally excluded whether polymorphisms that impair integrins at several levels could have an effect on the risk of melanoma when these proteins interact with different molecules involved, for instance, in signalling pathways, with the possibility of disrupting normal pathways. It still remains unclear, the relationship of the variants with their microenvironment (36, 37) . Future studies will have to elucidate to which extent integrins contribute to melanoma susceptibility, among other factors responsible for this disease.
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